: The AMEDEO Literature Guide

Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Bacterial Infections and Mycoses

Free Subscription

Articles published in Antimicrob Agents Chemother
Retrieve available abstracts of 390 articles:
HTML format
Text format

Single Articles

March 2010

OPATOWSKI L , Mandel J, Varon E, Boelle PY, et al
Antibiotic Dose Impact on Resistance Selection in the Community: A Mathematical Model of {beta}-Lactams and Streptococcus pneumoniae Dynamics.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

COLOMBO AL , Ngai AL, Bourque M, Bradshaw SK, et al
Caspofungin Use in Patients with Invasive Candidiasis caused by Common Non-albicans Candida Species: Review of the Caspofungin Database.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

SIMOR AE , Louie L, Watt C, Gravel D, et al
Antimicrobial Susceptibilities of Healthcare-Associated and Community-Associated Strains of Methicillin-Resistant Staphylococcus aureus (MRSA) from Hospitalized Patients in Canada, 1995-2008.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

WANG Q , Sun FJ, Liu Y, Xiong LR, et al
Enhancement of Biofilm Formation by Subinhibitory Macrolides in icaADBC-Positive and -Negative Clinical Isolates of Staphylococcus epidermidis.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

MOLINA-TORRES CA , Ocampo-Candiani J, Rendon A, Pucci MJ, et al
In vitro activity of a new Isothiazoloquinolone (ACH-702) against Mycobacterium tuberculosis and other mycobacteria.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

ANDO H , Kondo Y, Suetake T, Toyota E, et al
Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

PEREZ-ROTH E , Kwong SM, Alcoba-Florez J, Firth N, et al
Complete nucleotide sequence and comparative analysis of pPR9, a 41.7-kb conjugative staphylococcal multiresistance plasmid conferring high-level mupirocin resistance.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

COOMBS GW , Monecke S, Ehricht R, Slickers P, et al
Differentiation of CC59 Community-Associated Methicillin-Resistant Staphylococcus aureus in Western Australia.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

NANNINI EC , Stryjewski ME, Singh KV, Rude TH, et al
Determination of an Inoculum Effect with Various Cephalosporins among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

HE J , Yarbrough DK, Kreth J, Anderson MH, et al
A systematic approach to optimizing specifically-targeted antimicrobial peptides against Streptococcus mutans.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

VEDIYAPPAN G , Rossignol T, d'Enfert C
Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

KOSOWSKA-SHICK K , McGhee PL, Appelbaum PC
Affinity of Ceftaroline and Other {beta}-Lactams for Penicillin-Binding Proteins from Staphylococcus aureus and Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

SADOWY E , Kuch A, Gniadkowski M, Hryniewicz W, et al
Expansion and evolution of the Spain9V-ST156 Streptococcus pneumoniae clonal complex in Poland.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

TUOHY MJ , Reja V, Park S, Perlin DS, et al
The Use of High-Resolution Melt to Characterize Codon 54 of the cyp51A Gene of Aspergillus fumigatus on the Rotor-GeneTM 6000.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

KIRAZ N , Dag I, Yamac M, Kiremitci A, et al
Synergistic Activities of Three Triazoles with Caspofungin against Candida glabrata isolates Determined by Time-Kill, Etest and Disk Diffusion Methods.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

GAMARRA S , Rocha EM, Zhang YQ, Park S, et al
Mechanism of the Synergistic Effect of Amiodarone and Fluconazole in Candida albicans.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

February 2010

LUNDE CS , Rexer CH, Hartouni SR, Axt S, et al
Fluorescence Microscopy Demonstrates Enhanced Targeting of Telavancin to the Division Septum of Staphylococcus aureus.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

BETRIU C , Morales G, Rodriguez-Avial I, Culebras E, et al
Comparative Activity of TR-700 (Torezolid) Against Staphylococcal Blood Isolates Collected in Spain.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

CHEN H , Liu Y, Jiang X, Chen M, et al
Rapid change of methicillin-resistant Staphylococcus aureus clones in a tertiary care hospital of China over a fifteen-year period.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

ORDWAY DJ , Shanley CA, Caraway ML, Orme EA, et al
Evaluation of standard chemotherapy in the guinea pig model of tuberculosis.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

RULLAS J , Garcia JI, Beltran M, Cardona PJ, et al
A fast standardized therapeutic efficacy assay for drug discovery in tuberculosis.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

GARCIA-EFFRON G , Chua DJ, Tomada JR, Dipersio J, et al
Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

CANTON E , Espinel-Ingroff A, Peman J, Del Castillo L, et al
In Vitro Fungicidal Activity of Echinocandins against Candida metapsilosis, C. orthopsilosis and C. parapsilosis by Time Killing Studies.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

PINHO MD , Melo-Cristino J, Ramirez M
Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene pool with Streptoccocus pyogenes.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

HOEHAMER CF , Cummings ED, Hilliard GM, Rogers PD, et al
Changes in the Proteome of Candida albicans in Response to Azole, Polyene, and Echinocandin Antifungal Agents.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

BEN-AMI R , Lewis RE, Leventakos K, Latge JP, et al
A Cutaneous Model of Invasive Aspergillosis.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

FORTWENDEL JR , Juvvadi PR, Perfect BZ, Rogg LE, et al
Transcriptional Regulation of Chitin Synthases by Calcineurin Controls Paradoxical Growth of Aspergillus fumigatus in Response to Caspofungin.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

KADLEC K , Schwarz S
Identification of a plasmid-borne resistance gene cluster comprising the resistance genes erm(T), dfrK, and tet(L) in a porcine methicillin-resistant Staphylococcus aureus ST398 strain.
Antimicrob Agents Chemother. 2010;54:915-8.
PubMed Text format Related articles Abstract available

CALVO E , Pastor FJ, Rodriguez MM, Mayayo E, et al
Murine model of a disseminated infection by the novel fungus Fonsecaea monophora and successful treatment with posaconazole.
Antimicrob Agents Chemother. 2010;54:919-23.
PubMed Text format Related articles Abstract available

January 2010

BA BB , Arpin C, Bikie Bi Nso B, Dubois V, et al
Activity of linezolid in an in vitro pharmacokinetic-pharmacodynamic model using different dosages and Staphylococcus aureus and Enterococcus faecalis strains with either a hypermutator phenotype or not.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

MIYAZAKI T , Yamauchi S, Inamine T, Nagayoshi Y, et al
Roles of calcineurin and Crz1 in antifungal susceptibility and virulence of Candida glabrata.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

MAJCHRZYKIEWICZ JA , Lubelski J, Moll GN, Kuipers A, et al
Production of a class II two-component lantibiotic of Streptococcus pneumoniae using the class I nisin synthetic machinery and leader sequence.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

KRAKAUER T , Buckley M, Issaq HJ, Fox SD, et al
Rapamycin Protects Mice from Staphylococcal Enterotoxin B-Induced Toxic Shock and Blocks Cytokine Release In vitro and In Vivo.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

GARCIA-CONTRERAS L , Sung JC, Muttil P, Padilla D, et al
Dry Powder PA-824 Aerosols for the Treatment of Tuberculosis in Guinea Pigs.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

DANIEL A , Euler C, Collin M, Chahales P, et al
Synergism Between a Novel Chimeric Lysin and Oxacillin Protects Against Infection by Methicillin-Resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

PASCA MR , Degiacomi G, Ribeiro AL, Zara F, et al
Clinical Isolates of Mycobacterium tuberculosis in Four European Hospitals are Uniformly Susceptible to Benzothiazinones.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

MACCALLUM DM , Coste A, Ischer F, Jacobsen MD, et al
Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

TSUBAKISHITA S , Kuwahara-Arai K, Baba T, Hiramatsu K, et al
Staphylococcal cassette chromosome mec (SCCmec)-like element in Macrococcus caseolyticus.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

DENIS G , Oberson K, Buhlmann A, Gaumann R, et al
Attenuation of cerebrospinal fluid inflammation by the non-bacteriolytic antibiotic daptomycin vs ceftriaxone in experimental pneumococcal meningitis.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

HAENNI M , Galofaro L, Ythier M, Giddey M, et al
Penicillin-Binding Protein (PBP) Genes Alterations in Streptococcus uberis Presenting a Decreased Susceptibility to Penicillin.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

XU X , Cai L, Xiao M, Kong F, et al
Distribution of serotypes, genotypes and resistance determinants among macrolide-resistant Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

BINET R , Bowlin AK, Maurelli AT, Rank RG, et al
Impact of Azithromycin Resistant Mutations on the Virulence and Fitness of Chlamydia caviae in Guinea Pigs.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

KHLIF M , Bogreau H, Michel-Nguyen A, Ayadi A, et al
Trailing or paradoxical growth of Candida albicans when exposed to caspofungin is not associated with microsatellite genotypes.
Antimicrob Agents Chemother. 2010.
PubMed Text format Related articles Abstract available

December 2009

ROBLIN PM , Kohlhoff SA, Parker C, Hammerschlag MR, et al
In Vitro Activity of CEM-101, a New Fluoroketolide Antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

RUSLAMI R , Nijland HM, Adhiarta IG, Kariadi SH, et al
PHARMACOKINETICS OF ANTI TUBERCULOSIS DRUGS IN PULMONARY TUBERCULOSIS PATIENTS WITH TYPE-2 DIABETES.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

HUITRIC E , Verhasselt P, Koul A, Andries K, et al
Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

CHAPELAND-LECLERC F , Hennequin C, Papon N, Noel T, et al
Acquisition of flucytosine, azole and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

ESPINEL-INGROFF A , Canton E, Peman J, Martin-Mazuelo E, et al
Comparison of Anidulafungin MICs as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Method (M27-A3 document) and Etest for Candida spp. Isolates.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SKINNER MC , Kiselev AO, Isaacs CE, Mietzner TA, et al
Evaluation of WLBU2 peptide and 3-O-octyl-sn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

STRANDBERG KL , Peterson ML, Lin YC, Pack MC, et al
Glycerol Monolaurate Inhibits Candida, and Gardnerella vaginalis In Vitro and In Vivo but not Lactobacillus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

CHLEBOWICZ MA , Nganou K, Kozytska S, Arends JP, et al
Recombination between ccrC genes in a type V (5C2 ) Staphylococcal Chromosomal Cassette mec (SCCmec) of Staphylococcus aureus ST398 leads to MRSA - MSSA conversion in vivo.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MELETIADIS J , Pournaras S, Roilides E, Walsh TJ, et al
Defining Fractional Inhibitory Concentration Index Cutoffs for additive Interactions based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis and in vitro-in vivo Correlation Data for Antifungal Drug Combinations against Aspergillus f
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

November 2009

ADAM HJ , Louie L, Watt C, Gravel D, et al
Detection and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) in Canada: Results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

APPEL E , Vallon-Eberhard A, Rabinkov A, Brenner O, et al
THERAPY OF MURINE PULMONARY ASPERGILLOSIS WITH ANTIBODY-ALLIINASE CONJUGATES AND ALLIIN.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SHANG W , Davies TA, Flamm RK, Bush K, et al
Effects of Ceftobiprole and Oxacillin on mecA Expression in Methicillin-Resistant Staphylococcus aureus Clinical Isolates.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

WONG A , Reddy SP, Smyth DS, Aguero-Rosenfeld ME, et al
Polyphyletic Emergence of Linezolid-Resistant Staphylococci in the United States.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

JOUKHADAR C , Pillai S, Wennersten C, Moellering RC Jr, et al
Lack of Bactericidal Antagonism or Synergism In Vitro Between Oxacillin and Vancomycin Against Methicillin-Susceptible Strains of Staphylococcus Aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

LANGFORD ML , Hasim S, Nickerson KW, Atkin AL, et al
Activity and Toxicity of Farnesol Towards Candida albicans is Dependent on Growth Conditions.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

NIELSEN A , Nielsen KF, Frees D, Larsen TO, et al
Method for screening compounds that influence virulence gene expression in Staphylococcus aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MAJCHRZYKIEWICZ JA , Kuipers OP, Bijlsma JJ
Generic and specific adaptative response of Streptococcus pneumoniae to challenge with three distinct antimicrobial peptides: bacitracin, LL-37 and nisin.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

ULANOVA D , Novotna J, Smutna Y, Kamenik Z, et al
Mutasynthesis of lincomycin derivatives with activity against drug-resistant staphylococci.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MAVRIDOU E , Bruggemann RJ, Melchers WJ, Mouton JW, et al
Efficacy of Posaconazole against three clinical Aspergillus fumigatus Isolates with Mutations in the cyp51A Gene.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

HENRY X , Amoroso A, Coyette J, Joris B, et al
Interaction of ceftobiprole with the Enterococcus faecium low-affinity PBP5.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

TATTEVIN P , Basuino L, Bauer D, Diep BA, et al
Ceftobiprole is Superior to Vancomycin, Daptomycin, and Linezolid, for the Treatment of Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis in Rabbits.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MCGHEE P , Clark C, Kosowska-Shick K, Nagai K, et al
IN VITRO ACTIVITY OF CEM-101 AGAINST STREPTOCOCCUS PNEUMONIAE AND STREPTOCOCCUS PYOGENES WITH DEFINED MACROLIDE RESISTANCE MECHANISMS.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

ARENDRUP MC , Garcia-Effron G, Lass-Florl C, Gomez Lopez A, et al
Susceptibility testing of Candida species to echinocandins: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion and agar-dilution using RPMI and IsoSensitest medium.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

HEILMANN CJ , Schneider S, Barker KS, Rogers PD, et al
An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

FERNANDEZ J , Hilliard JJ, Abbanat D, Zhang W, et al
In Vivo Activity of Ceftobiprole in Murine Skin Infections Due to Staphylococcus aureus and Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

October 2009

BRENCIANI A , Bacciaglia A, Vignaroli C, Pugnaloni A, et al
Characterization of {Phi}m46.1, the Main Streptococcus pyogenes Element Carrying mef(A) and tet(O) Genes.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SMITH K , Gould KA, Ramage G, Gemmell CG, et al
The influence of tigecycline on the expression of virulence factors in biofilm-associated cells of methicillin resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

BIZZINI A , Entenza JM, Michielin O, Arnold I, et al
A Single Mutation in the Enzyme I of the Sugar Phosphotransferase System Confers Penicillin Tolerance to Streptococcus gordonii.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MARINE M , Pastor FJ, Guarro J
Efficacy of posaconazole in a murine disseminated infection by Candida tropicalis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

NAGAPPAN V , Boikov D, Vazquez JA
Assessment of the In-vitro Kinetic Activity of Caspofungin against Candida glabrata.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SAFI H , Fleischmann RD, Peterson SN, Jones MB, et al
Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MINAMI M , Kamimura T, Isaka M, Tatsuno I, et al
Clindamycin-induced CovS-mediated regulation of the production of the virulent exoproteins streptolysin O, NAD glycohydrolase, and streptokinase in Streptococcus pyogenes.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

RAGLE BE , Karginov VA, Wardenburg JB
Prevention and treatment of Staphylococcus aureus pneumonia with a {beta}-cyclodextrin derivative.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

BALDONI D , Steinhuber A, Zimmerli W, Trampuz A, et al
In Vitro Activity of Gallium Maltolate against Staphylococci in Logarithmic, Stationary and Biofilm Growth-Phase: Comparison of Conventional and Calorimetric Susceptibility Testing.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MONTES M , Tamayo E, Orden B, Larruskain J, et al
Prevalence and Clonal Characterization of Streptococcus pyogenes Clinical Isolates with Reduced Fluoroquinolone Susceptibility in Spain.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

LOCKE JB , Hilgers M, Shaw KJ
Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

September 2009

SCHMIDT S , Sabarinath SN, Barbour A, Abbanat D, et al
Pharmacokinetic/Pharmacodynamic Modeling of the In Vitro Activity of Oxazolidinone Antimicobial Agents Against Methicillin-Resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MANN PA , McNicholas PM, Chau AS, Patel R, et al
Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of Candida species.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

LOCKE JB , Hilgers M, Shaw KJ
Novel ribosomal mutations in Staphylococcus aureus identified through selection with the oxazolidinones linezolid and torezolid (TR-700).
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

JACQUELINE C , Caillon J, Le Mabecque V, Miegeville AF, et al
Assessment of the In Vivo Activity of a Novel Anti-MRSA Cephalosporin, Ceftaroline, Against Vancomycin-Susceptible and -Resistant Enterococcus faecalis Strains in a Rabbit Endocarditis Model: A Comparative Study with Linezolid and Vancomycin.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

JUGHELI L , Bzekalava N, de Rijk P, Fissette K, et al
High cross resistance between kanamycin, amikacin and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

DAVIS SL , Nuermberger EL, Um P, Vidal C, et al
Non-invasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

BRINCH KS , Sandberg A, Baudoux P, Van Bambeke F, et al
Plectasin shows Intracellular Activity against Staphylococcus aureus in Human THP-1 Monocytes and in the Mouse Peritonitis Model.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

VIDAILLAC C , Leonard SN, Rybak MJ
In Vitro Activity of Ceftaroline Against Methicillin-Resistant Staphylococcus aureus and heterogeneous Vancomycin-Intermediate S. aureus Using a Hollow Fiber Model.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

YOUNG LS
Reconsidering Some Approved Antimicrobial Agents for Tuberculosis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

KOOMANACHAI P , Crandon JL, Banevicius MA, Peng L, et al
Pharmacodynamic Profile of Tigecycline against Methicillin-Resistant Staphylococcus aureus in an Experimental Pneumonia Model.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

August 2009

Classification of Staphylococcal Cassette Chromosome mec (SCCmec): Guidelines for Reporting Novel SCCmec Elements.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

DUONG AD , Hong Duyen NT, Lan NT, Hoa DV, et al
Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

ARAUJO R , Espinel-Ingroff A
Comparison of assessment of oxygen consumption, E-test and broth microdilution CLSI M38-A2 methods for evaluation of the susceptibility of Aspergillus fumigatus to posaconazole.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MCMANUS BA , Moran GP, Higgins JA, Sullivan DJ, et al
A Ser29Leu Substitution in the Cytosine Deaminase Fca1p is Responsible for Clade-specific 5-Flucytosine Resistance in Candida dubliniensis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

VON GROLL A , Martin A, Jureen P, Hoffner S, et al
Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SUCHLAND RJ , Sandoz KM, Jeffrey BM, Stamm WE, et al
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

PARK SH , Yang SK, Yang DH, Kim KJ, et al
Six-month versus 9-month therapy for intestinal tuberculosis: A prospective randomized trial.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MANOSUTHI W , Sungkanuparph S, Tantanathip P, Mankatitham W, et al
Body Weight Cutoff for Daily Dosage of Efavirenz and 60-week Efficacy of Efavirenz-based Regimen in Co-infected HIV and Tuberculosis Patients Receiving Rifampin.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

ARIAS CA , Panesso D, Singh KV, Rice LB, et al
Co-Transfer of Antibiotic Resistance Genes and a hylEfm-Containing Virulence Plasmid in Enterococcus faecium.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

WEISS EC , Zielinska A, Beenken KE, Spencer HJ, et al
Impact of sarA on daptomycin susceptibility of Staphylococcus aureus biofilms in vivo.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

DEL POZO JL , Rouse MS, Euba G, Kang CI, et al
The Electricidal Effect is Active in an Experimental Model of Staphylococcus epidermidis Chronic Foreign Body Osteomyelitis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

RUKAYADI Y , Lee K, Han S, Yong D, et al
In Vitro Activities of Panduratin A against Clinical Staphylococcus Strains.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

OPPERMAN TJ , Kwasny SM, Williams JD, Khan AR, et al
Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

PEA F , Furlanut M, Viale P
What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice?
Antimicrob Agents Chemother. 2009;53:3608-9.
PubMed Text format Related articles

KIMKO H , Xu X, Nandy P, Samtani MN, et al
Pharmacodynamic profiling of ceftobiprole for treatment of complicated skin and skin structure infections.
Antimicrob Agents Chemother. 2009;53:3371-4.
PubMed Text format Related articles Abstract available

KANG CI , Rouse MS, Mandrekar JN, Steckelberg JM, et al
Anidulafungin treatment of candidal central nervous system infection in a murine model.
Antimicrob Agents Chemother. 2009;53:3576-8.
PubMed Text format Related articles Abstract available

HAWSER SP , Bouchillon SK, Hoban DJ, Badal RE, et al
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
Antimicrob Agents Chemother. 2009;53:3280-4.
PubMed Text format Related articles Abstract available

KEYAERTS E , Li S, Vijgen L, Rysman E, et al
Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice.
Antimicrob Agents Chemother. 2009;53:3416-21.
PubMed Text format Related articles Abstract available

AZEVEDO-VETHACKE M , Garten D, Groll C, Schreiber S, et al
Specific therapeutic schemes of omeprazole affect the orientation of Helicobacter pylori.
Antimicrob Agents Chemother. 2009;53:3511-4.
PubMed Text format Related articles Abstract available

DOLAN K , Montgomery S, Buchheit B, Didone L, et al
Antifungal activity of tamoxifen: in vitro and in vivo activities and mechanistic characterization.
Antimicrob Agents Chemother. 2009;53:3337-46.
PubMed Text format Related articles Abstract available

FERRAN AA , Kesteman AS, Toutain PL, Bousquet-Melou A, et al
Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection model.
Antimicrob Agents Chemother. 2009;53:3384-90.
PubMed Text format Related articles Abstract available

ZHAO Z , Ma Y, Dai C, Zhao R, et al
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates.
Antimicrob Agents Chemother. 2009;53:3472-7.
PubMed Text format Related articles Abstract available

CANNON CL , Hogue LA, Vajravelu RK, Capps GH, et al
In vitro and murine efficacy and toxicity studies of nebulized SCC1, a methylated caffeine-silver(I) complex, for treatment of pulmonary infections.
Antimicrob Agents Chemother. 2009;53:3285-93.
PubMed Text format Related articles Abstract available

RODRIGUEZ MM , Calvo E, Marine M, Pastor FJ, et al
Efficacy of liposomal amphotericin B combined with gamma interferon or granulocyte-macrophage colony-stimulating factor for treatment of systemic zygomycosis in mice.
Antimicrob Agents Chemother. 2009;53:3569-71.
PubMed Text format Related articles Abstract available

WARN PA , Sharp A, Parmar A, Majithiya J, et al
Pharmacokinetics and pharmacodynamics of a novel triazole, isavuconazole: mathematical modeling, importance of tissue concentrations, and impact of immune status on antifungal effect.
Antimicrob Agents Chemother. 2009;53:3453-61.
PubMed Text format Related articles Abstract available

PLACHOURAS D , Karvanen M, Friberg LE, Papadomichelakis E, et al
Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.
Antimicrob Agents Chemother. 2009;53:3430-6.
PubMed Text format Related articles Abstract available

LOUIE A , Fregeau C, Liu W, Kulawy R, et al
Pharmacodynamics of levofloxacin in a murine pneumonia model of Pseudomonas aeruginosa infection: determination of epithelial lining fluid targets.
Antimicrob Agents Chemother. 2009;53:3325-30.
PubMed Text format Related articles Abstract available

July 2009

MURILLO O , Garrigos C, Pachon ME, Euba G, et al
Efficacy of high doses of daptomycin vs. alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SADER HS , Fey PD, Fish DN, Limaye A, et al
Evaluation of vancomycin and daptomycin potency trends ("MIC creep") against methicillin-resistant Staphylococcus aureus collected in nine United States medical centers over five years (2002- 2006).
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SINGH SR , Bacon AE 3rd, Young DC, Couch KA, et al
In-Vitro 24-Hour Time Kill Studies of Vancomycin and Linezolid in Combination Versus Methicillin-Resistant Staphylococcus Aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

ALCAZAR-FUOLI L , Mellado E, Alastruey-Izquierdo A, Cuenca-Estrella M, et al
Specie identification and Antifungal Susceptibility Patterns of Species Belonging to Aspergillus section Nigri.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

GONZALEZ GM , Robledo E, Garza-Gonzalez E, Elizondo M, et al
Efficacy of Albaconazole against Candida albicans in Vaginitis Model.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

KOSOWSKA-SHICK K , Clark C, Pankuch GA, McGhee P, et al
ACTIVITY OF TELAVANCIN AGAINST STAPHYLOCOCCI AND ENTEROCOCCI BY MIC AND RESISTANCE SELECTION STUDIES.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

ALMEIDA D , Nuermberger E, Tasneen R, Rosenthal I, et al
Paradoxical effect of isoniazid on the activity of the rifampin-pyrazinamide combination in the mouse model of tuberculosis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

KUEHL R , Al-Bataineh S, Gordon O, Luginbuehl R, et al
Furanone enhances biofilm of staphylococci at subinhibitory concentrations by luxS repression.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MIRO JM , Garcia-de-la-Maria C, Armero Y, Soy D, et al
The Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in the Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SPREGHINI E , Orlando F, Santinelli A, Pisa E, et al
Anidulafungin in Combination with Amphotericin B against Aspergillus fumigatus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

HIGGINS PG , Rosato AE, Seifert H, Archer GL, et al
Differential Expression of ccrA in Methicillin Resistant Staphylococcus aureus Carrying SCCmec types II and type IVa elements.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

BANAEI N , Kincaid EZ, Lin SY, Desmond E, et al
Lipoprotein processing is essential for resistance of Mycobacterium tuberculosis to malachite green.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

KITAMURA A , Higuchi S, Hata M, Kawakami K, et al
Effect of {beta}-1,6-glucan inhibitors on the invasion process of Candida albicans: potential mechanism of its in vivo efficacy.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

HARIGAYA Y , Bulitta JB, Forrest A, Sakoulas G, et al
Vancomcyin Pharmacodynamics at Simulated Epithelial Lining Fluid Concentrations against Methicillin-Resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

GOUDE R , Amin AG, Chatterjee D, Parish T, et al
The EmbC arabinosyltransferase is inhibited by ethambutol in Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

LI M , Rigby K, Lai Y, Nair V, et al
Staphylococcus aureus mutant screen reveals interaction of the human antimicrobial peptide dermcidin with membrane phospholipids.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

AHMED NA , Petersen FC, Scheie AA
AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

HO YM , Sun YJ, Wong SY, Lee AS, et al
Contribution of dfrA and inhA Mutations to the Detection of Isoniazid-Resistant Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

HURDLE JG , Yendapally R, Sun D, Lee RE, et al
Evaluation of analogs of reutericyclin as prospective candidates for the treatment of staphylococcal skin infections.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

CUESTA I , Bielza C, Larranaga P, Cuenca-Estrella M, et al
Data mining validation of fluconazole breakpoints established by the European Committee on Antimicrobial Susceptibility Testing.
Antimicrob Agents Chemother. 2009;53:2949-54.
PubMed Text format Related articles Abstract available

MENG J , Wang H, Hou Z, Chen T, et al
Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting mecA.
Antimicrob Agents Chemother. 2009;53:2871-8.
PubMed Text format Related articles Abstract available

CLARK C , Kosowska-Shick K, McGhee P, Dewasse B, et al
Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains.
Antimicrob Agents Chemother. 2009;53:3118-21.
PubMed Text format Related articles Abstract available

SPELLBERG B , Andes D, Perez M, Anglim A, et al
Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis.
Antimicrob Agents Chemother. 2009;53:3122-5.
PubMed Text format Related articles Abstract available

SIONOV E , Chang YC, Garraffo HM, Kwon-Chung KJ, et al
Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence.
Antimicrob Agents Chemother. 2009;53:2804-15.
PubMed Text format Related articles Abstract available

ANDES D , Craig W, Nielsen LA, Kristensen HH, et al
In vivo pharmacodynamic characterization of a novel plectasin antibiotic, NZ2114, in a murine infection model.
Antimicrob Agents Chemother. 2009;53:3003-9.
PubMed Text format Related articles Abstract available

KRIEVINS D , Brandt R, Hawser S, Hadvary P, et al
Multicenter, randomized study of the efficacy and safety of intravenous iclaprim in complicated skin and skin structure infections.
Antimicrob Agents Chemother. 2009;53:2834-40.
PubMed Text format Related articles Abstract available

POPE CE , Carter PE, Heffernan HM
CMY-29 and CMY-30, two novel plasmid-mediated AmpC beta-lactamases.
Antimicrob Agents Chemother. 2009;53:3178.
PubMed Text format Related articles

PITOUT JD , Gregson DB, Campbell L, Laupland KB, et al
Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections.
Antimicrob Agents Chemother. 2009;53:2846-51.
PubMed Text format Related articles Abstract available

RUPPE E , Woerther PL, Diop A, Sene AM, et al
Carriage of CTX-M-15-producing Escherichia coli isolates among children living in a remote village in Senegal.
Antimicrob Agents Chemother. 2009;53:3135-7.
PubMed Text format Related articles Abstract available

JI B , Chauffour A, Aubry A, Robert J, et al
Impacts of dosing frequency of the combination rifampin-streptomycin on its bactericidal and sterilizing activities against Mycobacterium ulcerans in mice.
Antimicrob Agents Chemother. 2009;53:2955-9.
PubMed Text format Related articles Abstract available

GASTMEIER P , Sohr D, Geffers C, Ruden H, et al
Early- and late-onset pneumonia: is this still a useful classification?
Antimicrob Agents Chemother. 2009;53:2714-8.
PubMed Text format Related articles Abstract available

NICASIO AM , Crandon JL, Nicolau DP
In vivo pharmacodynamic profile of tigecycline against phenotypically diverse Escherichia coli and Klebsiella pneumoniae isolates.
Antimicrob Agents Chemother. 2009;53:2756-61.
PubMed Text format Related articles Abstract available

June 2009

WU M , von Eiff C, Al Laham N, Tsuji BT, et al
Vancomycin and Daptomycin Pharmacodynamics Differ Against a Site-Directed Staphylococcus epidermidis Mutant Displaying the Small Colony Variant Phenotype.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

RAMON-GARCIA S , Martin C, Thompson CJ, Ainsa JA, et al
The role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses and growth.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

HARRIOTT MM , Noverr MC
Candida albicans and Staphylococcus aureus Form Polymicrobial Biofilms: Effects on Antimicrobial Resistance.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

LEMAIRE S , Van Bambeke F, Tulkens PM
Cellular accumulation and pharmacodynamic evaluation of the Intracellular activity of CEM-101, a novel fluoroketolide, towards Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

ENTENZA JM , Haldimann A, Giddey M, Lociuro S, et al
Efficacy of Iclaprim against Wild-Type and Thymidine kinase-Deficient Methicillin-Resistant Staphylococcus aureus in an In Vitro Fibrin-Clot Model.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MCGEE B , Dietze R, Hadad DJ, Molino LP, et al
Population Pharmacokinetics of Linezolid in Adults with Pulmonary Tuberculosis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

FORGACS P , Wengenack NL, Hall L, Zimmerman SK, et al
Tuberculosis and Trimethoprim-Sulfamethoxazole.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

FERREIRA JA , Carr JH, Starling CE, de Resende MA, et al
Biofilm formation and the effect of caspofungin on the biofilm structure of Candida spp. bloodstream isolates.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

GARCIA-EFFRON G , Lee S, Park S, Cleary JD, et al
Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-{beta}-D-glucan synthase: implication for the existing susceptibility breakpoint.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

BOUMGHAR-BOURTCHAI L , Dhalluin A, Malbruny B, Galopin S, et al
Influence of Recombination on Development of Mutational Resistance to Linezolid in Enterococcus faecalis JH2-2.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SUN W , Chen H, Liu Y, Zhao C, et al
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) from 14 cities in China.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

RUIZ N
Streptococcus pyogenes YtgP (Spy_0390) complements Escherichia coli strains depleted of the putative peptidoglycan flippase MurJ.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

TAKAZONO T , Izumikawa K, Mihara T, Kosai K, et al
Efficacy of combination antifungal therapy of intraperitoneal micafungin with aerosolized liposomal amphotericin B in murine invasive pulmonary aspergillosis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MOUBARECK C , Meziane-Cherif D, Courvalin P, Perichon B, et al
VanA-type Staphylococcus aureus VRSA-7 is Partially Dependent on Vancomycin for Growth.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

PERICHON B , Courvalin P
VanA-type vancomycin-resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

HORNE KC , Howden BP, Grabsch EA, Graham M, et al
Prospective Comparison of the Clinical Impact of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (hVISA) and Vancomycin- Susceptible MRSA.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

NANNINI EC , Stryjewski ME, Singh KV, Bourgogne A, et al
Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin Susceptible Staphylococcus aureus: Frequency and Possible Cause of Cefazolin Treatment failure.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

WONG H , Louie L, Watt C, Sy E, et al
Characterization of ermA in Macrolide-Susceptible Strains of Methicillin-Resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

KARLOWSKY JA , Kaplan N, Hafkin B, Hoban DJ, et al
AFN-1252, a FabI Inhibitor, Demonstrates a Staphylococcal-Specific Spectrum of Activity.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

EGUCHI K , Kanazawa K, Eriguchi Y, Ueda Y, et al
Pharmacodynamics of SMP-601 (PTZ601) against Vancomycin-Resistant Enterococcus faecium and Methicillin-Resistant Staphylococcus aureus in Neutropenic Murine Thigh Infection Models.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

ARENDRUP MC , Cuenca-Estrella M, Donnelly JP, Lass-Florl C, et al
Association of fluconazole pharmacodynamics with mortality in patients with candidemia.
Antimicrob Agents Chemother. 2009;53:2704-5.
PubMed Text format Related articles

HAN X , Ito T, Takeuchi F, Ma XX, et al
Identification of a novel variant of staphylococcal cassette chromosome mec, type II.5, and Its truncated form by insertion of putative conjugative transposon Tn6012.
Antimicrob Agents Chemother. 2009;53:2616-9.
PubMed Text format Related articles Abstract available

HEO YJ , Lee YR, Jung HH, Lee J, et al
Antibacterial efficacy of phages against Pseudomonas aeruginosa infections in mice and Drosophila melanogaster.
Antimicrob Agents Chemother. 2009;53:2469-74.
PubMed Text format Related articles Abstract available

PELEG AY , Jara S, Monga D, Eliopoulos GM, et al
Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics.
Antimicrob Agents Chemother. 2009;53:2605-9.
PubMed Text format Related articles Abstract available

SPYRIDAKI I , Psaroulaki A, Vranakis I, Tselentis Y, et al
Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.
Antimicrob Agents Chemother. 2009;53:2690-2.
PubMed Text format Related articles Abstract available

LEPERCQ J , Treluyer JM, Auger C, Raymond J, et al
Evaluation of cefotaxime and desacetylcefotaxime concentrations in cord blood after intrapartum prophylaxis with cefotaxime.
Antimicrob Agents Chemother. 2009;53:2342-5.
PubMed Text format Related articles Abstract available

LANDERSDORFER CB , Kinzig M, Bulitta JB, Hennig FF, et al
Bone penetration of amoxicillin and clavulanic acid evaluated by population pharmacokinetics and Monte Carlo simulation.
Antimicrob Agents Chemother. 2009;53:2569-78.
PubMed Text format Related articles Abstract available

OKUYAMA-NISHIDA Y , Akiyama N, Sugimori G, Nomura K, et al
Prevention of death in bacterium-infected mice by a synthetic antimicrobial peptide, L5, through activation of host immunity.
Antimicrob Agents Chemother. 2009;53:2510-6.
PubMed Text format Related articles Abstract available

May 2009

MARINE M , Pastor FJ, Serena C, Guarro J, et al
Efficacy of triazoles in a murine disseminated infection by Candida krusei.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

KADLEC K , Schwarz S
Identification of a Novel ABC Transporter Gene, vga(C), located on a Multiresistance Plasmid from a Porcine Methicillin-Resistant Staphylococcus aureus ST398 strain.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

FEUERRIEGEL S , Cox HS, Zarkua N, Karimovich HA, et al
Sequence analyses of just four genes to detect extensively drug resistant tuberculosis among MDR-TB patients undergoing treatment.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

LLARRULL LI , Fisher JF, Mobashery S
Molecular Basis and Phenotype of Methicillin Resistance in Staphylococcus aureus and Insights Into New {beta}-lactams That Meet the Challenge.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

GUMBO T , Siyambalapitiyage Dona CS, Meek C, Leff R, et al
Pharmacokinetics-Pharmacodynamics of Pyrazinamide In A Novel In Vitro Model of Tuberculosis for Sterilizing Effect: A Paradigm for Faster Assessment of New Antituberculosis Drugs.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

LAPLANTE KL , Mermel LA
In vitro activity of Telavancin and Vancomycin against Biofilm-Producing Staphylococcus aureus, S. epidermidis and Enterococcus faecalis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

YAMAMOTO K , Yanagihara K, Sugahara K, Imamura Y, et al
In vitro activity of garenoxacin against Streptococcus pneumoniae mutants with characterized resistance mechanisms.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

RODVOLD KA , Nicolau DP, Lodise TP, Khashab M, et al
Identifying Exposure Targets for the Treatment of Staphylococcal Pneumonia with Ceftobiprole.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

STEWART PS , Davison WM, Steenbergen JN
Daptomycin Rapidly Penetrates a Staphylococcus epidermidis Biofilm.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

KATAYAMA Y , Murakami-Kuroda H, Cui L, Hiramatsu K, et al
Selection of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus by Imipenem.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

PRESTERL E , Hajdu S, Lassnigg AM, Hirschl AM, et al
Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline and ceftriaxone on Staphylococcus epidermidis biofilms.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

PANNU J , McCarthy A, Martin A, Hamouda T, et al
NB-002, a Novel Nanoemulsion with Broad Antifungal Activity Against Dermatophytes, Other Filamentous Fungi and Candida albicans.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

FLORENT M , Noel T, Ruprich-Robert G, Da Silva B, et al
Nonsense and missense mutations in FCY2 and in FCY1 genes are responsible for flucytosine resistance and flucytosine-fluconazole cross-resistance in clinical isolates of Candida lusitaniae.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

LEONARD SN , Vidaillac C, Rybak MJ
Activity of Telavancin Against Staphylococcus aureus of Varying Vancomycin Susceptibilities in an In Vitro Pharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

NIKONENKO BV , Reddy VM, Protopopova M, Bogatcheva E, et al
Activity of SQ641, a Capuramycin Analog, in Murine Model of Tuberculosis (TB).
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

CAVALHEIRO AS , Maboni G, de Azevedo MI, Argenta JS, et al
In Vitro activity of terbinafine combined with caspofungin and azoles against Pythium insidiosum.
Antimicrob Agents Chemother. 2009;53:2136-8.
PubMed Text format Related articles Abstract available

SADER HS , Fritsche TR, Jones RN
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
Antimicrob Agents Chemother. 2009;53:2171-5.
PubMed Text format Related articles Abstract available

ALDEYAB MA , Harbarth S, Vernaz N, Kearney MP, et al
Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients.
Antimicrob Agents Chemother. 2009;53:2082-8.
PubMed Text format Related articles Abstract available

FABRE L , Delaune A, Espie E, Nygard K, et al
Chromosomal integration of the extended-spectrum beta-lactamase gene blaCTX-M-15 in Salmonella enterica serotype Concord isolates from internationally adopted children.
Antimicrob Agents Chemother. 2009;53:1808-16.
PubMed Text format Related articles Abstract available

HILLIARD JJ , Fernandez J, Melton J, Macielag MJ, et al
In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
Antimicrob Agents Chemother. 2009;53:2028-33.
PubMed Text format Related articles Abstract available

VETTORETTI L , Plesiat P, Muller C, El Garch F, et al
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Antimicrob Agents Chemother. 2009;53:1987-97.
PubMed Text format Related articles Abstract available

WAITES KB , Crabb DM, Duffy LB
Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101.
Antimicrob Agents Chemother. 2009;53:2139-41.
PubMed Text format Related articles Abstract available

GOOTZ TD , Lescoe MK, Dib-Hajj F, Dougherty BA, et al
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
Antimicrob Agents Chemother. 2009;53:1998-2004.
PubMed Text format Related articles Abstract available

THOMPSON GR 3RD , Rinaldi MG, Pennick G, Dorsey SA, et al
Posaconazole therapeutic drug monitoring: a reference laboratory experience.
Antimicrob Agents Chemother. 2009;53:2223-4.
PubMed Text format Related articles

BLACKMAN NORTHWOOD J , Del Grosso M, Cossins LR, Coley MD, et al
Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes isolated between 1999 and 2005.
Antimicrob Agents Chemother. 2009;53:1921-5.
PubMed Text format Related articles Abstract available

LANDERSDORFER CB , Kinzig M, Hennig FF, Bulitta JB, et al
Penetration of moxifloxacin into bone evaluated by Monte Carlo simulation.
Antimicrob Agents Chemother. 2009;53:2074-81.
PubMed Text format Related articles Abstract available

PICAO RC , Poirel L, Gales AC, Nordmann P, et al
Further identification of CTX-M-2 extended-spectrum beta-lactamase in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2009;53:2225-6.
PubMed Text format Related articles

PEA F , Furlanut M, Negri C, Pavan F, et al
Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients.
Antimicrob Agents Chemother. 2009;53:1863-7.
PubMed Text format Related articles Abstract available

BAINES SD , Freeman J, Wilcox MH
Tolevamer is not efficacious in the neutralization of cytotoxin in a human gut model of Clostridium difficile infection.
Antimicrob Agents Chemother. 2009;53:2202-4.
PubMed Text format Related articles Abstract available

SEED KD , Dennis JJ
Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex.
Antimicrob Agents Chemother. 2009;53:2205-8.
PubMed Text format Related articles Abstract available

DAIKOS GL , Petrikkos P, Psichogiou M, Kosmidis C, et al
Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections.
Antimicrob Agents Chemother. 2009;53:1868-73.
PubMed Text format Related articles Abstract available

TRIFILIO SM , Yarnold PR, Scheetz MH, Pi J, et al
Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation.
Antimicrob Agents Chemother. 2009;53:1793-6.
PubMed Text format Related articles Abstract available

CUENCA-ESTRELLA M , Gomez-Lopez A, Mellado E, Monzon A, et al
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
Antimicrob Agents Chemother. 2009;53:2192-5.
PubMed Text format Related articles Abstract available

DULJASZ W , Gniadkowski M, Sitter S, Wojna A, et al
First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.
Antimicrob Agents Chemother. 2009;53:2221-2.
PubMed Text format Related articles

RODRIGUEZ MM , Calvo E, Serena C, Marine M, et al
Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans.
Antimicrob Agents Chemother. 2009;53:2153-5.
PubMed Text format Related articles Abstract available

April 2009

SADER HS , Rhomberg PR, Jones RN
Comparison of Broth Microdilution and Etest Method Results when Testing Vancomycin and Daptomycin against Methicillin-Resistant Staphylococcus aureus: A Nine Hospital Study.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

JOHNSON JR , Menard M, Johnston B, Kuskowski MA, et al
Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada (2002-2004).
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

VANDEPUTTE P , Tronchin G, Rocher F, Renier G, et al
Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

WEISMAN LE , Thackray HM, Garcia-Prats JA, Nesin M, et al
A Phase 1/2 Double Blind, Placebo-Controlled, Dose Escalation, Safety, and Pharmacokinetic Study in Very Low Birth Weight Neonates of Pagibaximab (BSYX-A110), an Anti-Staphylococcal Monoclonal Antibody for the Prevention of Staphylococcal Bloodstream Inf
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

CANTON E , Peman J, Valentin A, Espinel-Ingroff A, et al
IN VITRO ACTIVITY OF ECHINOCANDINS AGAINST CANDIDA KRUSEI BY THREE METHODS: MINIMAL INHIBITORY AND FUNGICIDAL CONCENTRATION AND TIME-KILLING STUDIES.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

DAROUICHE RO , Mansouri MD, Schneidkraut MJ
Comparative Efficacy of Telavancin and Vancomycin in Preventing Device-Associated Colonization and Infection by Staphylococcus aureus in Rabbits.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

EGERMANN U , Stanga Z, Ramin A, Acosta F, et al
The Combination of Daptomycin plus Ceftriaxone was more active than Vancomycin plus Ceftriaxone in Experimental Meningitis after Addition of Dexamethasone.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SHIRTLIFF ME , Krom BP, Meijering RA, Peters BM, et al
Farnesol-Induced Apoptosis in Candida albicans.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SENYUREK I , Paulmann M, Sinnberg T, Kalbacher H, et al
Dermcidin-derived peptides show a different mode of action against Staphylococcus aureus than the cathelicidin LL-37.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

NGUYEN KT , Ta P, Hoang BT, Cheng S, et al
Anidulafungin is fungicidal and exerts a variety of post-antifungal effects against Candida albicans, C. glabrata, C. parapsilosis and C. krusei isolates.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

VAUDAUX P , Fleury B, Gjinovci A, Huggler E, et al
Comparison of Tigecycline and Vancomycin for Treatment of Experimental Foreign Body Infection due to Methicillin-Resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

XU P , Li X, Zhao M, Gui X, et al
Prevalence of Fluoroquinolone Resistance among Tuberculosis Patients in Shanghai, China.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

JOHN AK , Baldoni D, Haschke M, Rentsch K, et al
Efficacy of Daptomycin in Implant-Associated Infection due to Methicillin-Resistant Staphylococcus aureus (MRSA): The Importance of Combination with Rifampin.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MCKAY GA , Beaulieu S, Sarmiento I, Arhin FF, et al
Impact of human serum albumin on oritavancin in vitro activity against enterococci.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

DE R , Kundu P, Swarnakar S, Ramamurthy T, et al
Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice.
Antimicrob Agents Chemother. 2009;53:1592-7.
PubMed Text format Related articles Abstract available

NICASIO AM , Ariano RE, Zelenitsky SA, Kim A, et al
Population pharmacokinetics of high-dose, prolonged-infusion cefepime in adult critically ill patients with ventilator-associated pneumonia.
Antimicrob Agents Chemother. 2009;53:1476-81.
PubMed Text format Related articles Abstract available

PETERSEN PJ , Jones CH, Venkatesan AM, Bradford PA, et al
Efficacy of piperacillin combined with the Penem beta-lactamase inhibitor BLI-489 in murine models of systemic infection.
Antimicrob Agents Chemother. 2009;53:1698-700.
PubMed Text format Related articles Abstract available

RUIZ-CENDOYA M , Marine M, Rodriguez MM, Guarro J, et al
Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum.
Antimicrob Agents Chemother. 2009;53:1705-8.
PubMed Text format Related articles Abstract available

DELEON K , Balldin F, Watters C, Hamood A, et al
Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice.
Antimicrob Agents Chemother. 2009;53:1331-7.
PubMed Text format Related articles Abstract available

CHAMBERS HF , Basuino L, Diep BA, Steenbergen J, et al
Relationship between susceptibility to daptomycin in vitro and activity in vivo in a rabbit model of aortic valve endocarditis.
Antimicrob Agents Chemother. 2009;53:1463-7.
PubMed Text format Related articles Abstract available

SIARKOU VI , Vitti D, Protonotariou E, Ikonomidis A, et al
Molecular epidemiology of outbreak-related pseudomonas aeruginosa strains carrying the novel variant blaVIM-17 metallo-beta-lactamase gene.
Antimicrob Agents Chemother. 2009;53:1325-30.
PubMed Text format Related articles Abstract available

AL-HASAN MN , Wilson JW, Lahr BD, Thomsen KM, et al
Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli.
Antimicrob Agents Chemother. 2009;53:1386-94.
PubMed Text format Related articles Abstract available

LAUNAY E , Joram N, Jacqueline C, Miegeville AF, et al
Efficacy of ciprofloxacin in an experimental model of Escherichia coli chorioamnionitis in rabbits.
Antimicrob Agents Chemother. 2009;53:1624-7.
PubMed Text format Related articles Abstract available

FREIFELD A , Proia L, Andes D, Baddour LM, et al
Voriconazole use for endemic fungal infections.
Antimicrob Agents Chemother. 2009;53:1648-51.
PubMed Text format Related articles Abstract available

XU Y , Pang G, Gao C, Zhao D, et al
In vitro comparison of the efficacies of natamycin and silver nitrate against ocular fungi.
Antimicrob Agents Chemother. 2009;53:1636-8.
PubMed Text format Related articles Abstract available

SALVATORE CM , Techasaensiri C, Tagliabue C, Katz K, et al
Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia.
Antimicrob Agents Chemother. 2009;53:1546-51.
PubMed Text format Related articles Abstract available

BRYAN RA , Jiang Z, Huang X, Morgenstern A, et al
Radioimmunotherapy is effective against high-inoculum Cryptococcus neoformans infection in mice and does not select for radiation-resistant cryptococcal cells.
Antimicrob Agents Chemother. 2009;53:1679-82.
PubMed Text format Related articles Abstract available

March 2009

MURAYAMA SY , Seki C, Sakata H, Sunaoshi K, et al
Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients with invasive infections, ranging from newborns to the elderly.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

FOUCAULT ML , Courvalin P, Grillot-Courvalin C
Fitness cost of VanA-type vancomycin resistance in methicillin resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MISHRA NN , Yang SJ, Sawa A, Rubio A, et al
Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA).
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

PAI MP
Antifungal Combinations against Simulated Candida albicans Endocardial Vegetations.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

JACOBSON MJ , Steckelberg KE, Piper KE, Steckelberg JM, et al
In vitro Activity of Micafungin against Planktonic and Sessile Candida albicans.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

ZAREMBER KA , Cruz AR, Huang CY, Gallin JI, et al
Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

PETRAITIS V , Petraitiene R, Hope WW, Meletiadis J, et al
Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: In Vitro and In Vivo Correlation of the Concentration and Dose Dependent Interaction between Anidulafungin and Voriconazole by Bliss Independence Drug Interaction Analysis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

EUBA G , Murillo O, Fernandez-Sabe N, Mascaro J, et al
Oral Rifampin-Cotrimoxazole Combination vs Intravenous Cloxacillin in Chronic Staphylococcal Osteomyelitis: a Long-term Follow-up Trial.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

LANNERGARD J , Norstrom T, Hughes D
Genetic determinants of resistance to fusidic acid among clinical bacteremia isolates of Staphylococcus aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

WEISS EC , Spencer HJ, Daily SJ, Weiss BD, et al
Impact of sarA on the antibiotic susceptibility of Staphylococcus aureus in a catheter-associated in vitro model of biofilm formation.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

LEMAIRE S , Glupczynski Y, Duval V, Joris B, et al
Activity of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages, keratinocytes) forms of Methicillin-Sensitive (MSSA) and Methicillin-Resistant Staphylococcus aureus (MRSA).
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

FENG X , Reddy VK, Mayanja-Kizza H, Weiss LM, et al
Therapeutic evaluation of polyamine analogue drug candidates against Enterocytozoon bieneusi in the SCID mouse model.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

TOLMAN JA , Wiederhold NP, McConville JT, Najvar LK, et al
Inhaled Voriconazole for the Prevention of Invasive Pulmonary Aspergillosis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

YANG SJ , Xiong YQ, Dunman PM, Schrenzel J, et al
Regulation of mprF in daptomycin-nonsusceptible Staphylococcus aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MULLER-SERIEYS C , Saleh Mghir A, Massias L, Fantin B, et al
Bactericidal Activity of the Combination of Levofloxacin with Rifampin in Experimental Prosthetic Knee Infection in Rabbits due to Methicillin-Susceptible Staphylococcus aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

BECKER P , Hakenbeck R, Henrich B
An ABC transporter of Streptococcus pneumoniae involved in susceptibility to vancoresmycin and bacitracin.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

CLEMONS KV , Capilla J, Sobel RA, Martinez M, et al
Comparative efficacy of Abelcet and AmBisome against coccidioidal meningitis in rabbits.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SIIRA L , Rantala M, Jalava J, Hakanen AJ, et al
Temporal trends of antimicrobial resistance and clonality of invasive Streptococcus pneumoniae in Finland, 2002-2006.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SAN MILLAN A , Depardieu F, Godreuil S, Courvalin P, et al
VanB-type Enterococcus faecium clinical isolate successively inducibly resistant to, dependent on, and constitutively resistant to vancomycin.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

IZQUIERDO E , Cai Y, Marchioni E, Ennahar S, et al
Genetic identification of the bacteriocins produced by Enterococcus faecium IT62 and evidence that bacteriocin 32 is identical to enterocin IT.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

XIN D , Mi Z, Han X, Qin L, et al
Molecular Mechanisms of Macrolide Resistance in Clinical Isolates of Mycoplasma pneumoniae from China.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

LIU Y , Ye X, Zhang H, Xu X, et al
Antimicrobial Susceptibility of Mycoplasma pneumoniae Isolates and Molecular Analysis on Macrolide-Resistant Strains from Shanghai China.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

PAKYZ AL , Oinonen M, Polk RE
Relationship between Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

BEETON ML , Chalker VJ, Maxwell NC, Kotecha S, et al
Concurrent titration and determination of antibiotic resistance in Ureaplasma species with identification of novel point mutations in genes associated with resistance.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

DEPARDIEU F , Foucault ML, Bell J, Dubouix A, et al
New combinations of mutations in VanD-type Vancomycin Resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

BEERNAERT LA , Pasmans F, Van Waeyenberghe L, Dorrestein GM, et al
Avian Aspergillus fumigatus strains resistant to both itraconazole and voriconazole.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

HUGHES DW , Frei CR, Maxwell PR, Green K, et al
Continuous vs. Intermittent Infusion Oxacillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Infective Endocarditis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

WANG M , Guo Q, Xu X, Wang X, et al
New Plasmid-Mediated Quinolone Resistance Gene, qnrC, Found in a Clinical Isolate of Proteus mirabilis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

ZHANG H
Sialidase fusion protein as inhibitor of infection by influenza virus.
Antimicrob Agents Chemother. 2009;53:1297.
PubMed Text format Related articles

PRAKASH V , Lewis JS 2nd, Herrera ML, Wickes BL, et al
Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases.
Antimicrob Agents Chemother. 2009;53:1278-80.
PubMed Text format Related articles Abstract available

DIMOPOULOS G , Velegraki A, Falagas ME
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece.
Antimicrob Agents Chemother. 2009;53:1242-4.
PubMed Text format Related articles Abstract available

BERGMAN M , Nyberg ST, Huovinen P, Paakkari P, et al
Association between antimicrobial consumption and resistance in Escherichia coli.
Antimicrob Agents Chemother. 2009;53:912-7.
PubMed Text format Related articles Abstract available

SAEZ-LLORENS X , Macias M, Maiya P, Pineros J, et al
Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age.
Antimicrob Agents Chemother. 2009;53:869-75.
PubMed Text format Related articles Abstract available

ZELLER V , Durand F, Kitzis MD, Lhotellier L, et al
Continuous cefazolin infusion to treat bone and joint infections: clinical efficacy, feasibility, safety, and serum and bone concentrations.
Antimicrob Agents Chemother. 2009;53:883-7.
PubMed Text format Related articles Abstract available

SHARMA S , Thomas D, Marlett J, Manchester M, et al
Efficient neutralization of antibody-resistant forms of anthrax toxin by a soluble receptor decoy inhibitor.
Antimicrob Agents Chemother. 2009;53:1210-2.
PubMed Text format Related articles Abstract available

CHEN YT , Liao TL, Liu YM, Lauderdale TL, et al
Mobilization of qnrB2 and ISCR1 in plasmids.
Antimicrob Agents Chemother. 2009;53:1235-7.
PubMed Text format Related articles Abstract available

KIMKO H , Murthy B, Xu X, Nandy P, et al
Population pharmacokinetic analysis of ceftobiprole for treatment of complicated skin and skin structure infections.
Antimicrob Agents Chemother. 2009;53:1228-30.
PubMed Text format Related articles Abstract available

ARROYO LA , Mateos I, Gonzalez V, Aznar J, et al
In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group.
Antimicrob Agents Chemother. 2009;53:1295-6.
PubMed Text format Related articles

MORGENSTERN K , Baljer G, Norris DE, Kraiczy P, et al
In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease.
Antimicrob Agents Chemother. 2009;53:1281-4.
PubMed Text format Related articles Abstract available

DEFIFE R , Scheetz MH, Feinglass JM, Postelnick MJ, et al
Effect of differences in MIC values on clinical outcomes in patients with bloodstream infections caused by gram-negative organisms treated with levofloxacin.
Antimicrob Agents Chemother. 2009;53:1074-9.
PubMed Text format Related articles Abstract available

February 2009

MATHYS V , Wintjens R, Lefevre P, Bertout J, et al
Molecular genetics of para-aminosalicylic acid (PAS) resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

VAN DE SANDE WW , Mathot RA, Ten Kate MT, van Vianen W, et al
Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SCHULTHESS B , Meier S, Homerova D, Goerke C, et al
Functional characterization of the {sigma}B-dependent yabJ-spoVG operon in Staphylococcus aureus: role in methicillin and glycopeptide resistance.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SHIBATA H , Nakano T, Parvez MA, Furukawa Y, et al
Triple combinations of lower and longer alkyl gallates and oxacillin improve antibiotic synergy against methicillin-resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

TSAO S , Rahkhoodaee F, Raymond M
Relative contribution of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MCNAMARA PJ , Syverson RE, Milligan-Myhre K, Frolova O, et al
Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus TSST-1 production.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

ANTONOPOULOU S , Aoun M, Alexopoulos EC, Baka S, et al
Fenticonazole activity by the EUCAST and CLSI methods against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

TRACZEWSKI MM , Katz BD, Steenbergen JN, Brown SD, et al
Inhibitory and Bactericidal Activity of Daptomycin, Vancomycin and Teicoplanin against Methicillin-Resistant Staphylococcus aureus Collected from 1985 to 2007.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SANDBERG A , Hessler JH, Skov RL, Blom J, et al
Intracellular activity of antibiotics against Staphylococcus aureus in the mouse peritonitis model.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

KAAKOUSH NO , Asencio C, Megraud F, Mendz GL, et al
A redox basis for metronidazole resistance in Helicobacter pylori.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

KARLSSON M , Folster J, Pecic G, Joyce K, et al
Emergence of Plasmid-mediated Quinolone Resistance among Non-Typhi Salmonella enterica Isolated from Humans in the United States.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

NGUYEN HA , Denis O, Vergison A, Tulkens PM, et al
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus Small Colony Variant isolated from a cystic fibrosis patient : 2. Study of antibiotic combinations.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

HEDBERG ST , Fredlund H, Nicolas P, Caugant DA, et al
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt 2000-2006 - phenotypic and genotypic perspectives.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

OSTERGAARD C , Sandvang D, Frimodt-Moller N, Kristensen HH, et al
High CSF penetration and potent CSF bactericidal activity of NZ2114 - a novel Plectasin variant - during experimental pneumococcal meningitis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

NGUYEN HA , Denis O, Vergison A, Theunis A, et al
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus Small Colony Variant isolated from a cystic fibrosis patient : 1. Pharmacodynamic evaluation and comparison with isogenic normal phenotype and
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

BRAVETTI AL , Mesnage S, Lefort A, Chau F, et al
Contribution of the AtlA Autolysin to the Bactericidal Activity of Amoxicillin Against Enterococcus faecalis JH2-2.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

SKINNER MC , Stamm WE, Lampe ML
Chlamydia trachomatis Laboratory Strains vs. Recent Clinical Isolates: Implications for Routine Microbicide Testing.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

MANDRAS N , Tullio V, Allizond V, Scalas D, et al
In vitro activity of fluconazole and voriconazole against clinical isolates of Candida spp. determined by disk diffusion testing in Turin (Italy).
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

WAGENLEHNER FM , Wagenlehner C, Redman R, Weidner W, et al
Urinary Bactericidal Activity of Doripenem versus Levofloxacin in Patients with Complicated Urinary Tract Infections or Pyelonephritis.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

NAVON-VENEZIA S , Leavitt A, Schwaber MJ, Rasheed JK, et al
First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States.
Antimicrob Agents Chemother. 2009;53:818-20.
PubMed Text format Related articles Abstract available

WELCH TJ , Evenhuis J, White DG, McDermott PF, et al
IncA/C plasmid-mediated florfenicol resistance in the catfish pathogen Edwardsiella ictaluri.
Antimicrob Agents Chemother. 2009;53:845-6.
PubMed Text format Related articles

PHAN MD , Kidgell C, Nair S, Holt KE, et al
Variation in Salmonella enterica serovar typhi IncHI1 plasmids during the global spread of resistant typhoid fever.
Antimicrob Agents Chemother. 2009;53:716-27.
PubMed Text format Related articles Abstract available

JONES CH , Tuckman M, Keeney D, Ruzin A, et al
Characterization and sequence analysis of extended-spectrum-{beta}-lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials.
Antimicrob Agents Chemother. 2009;53:465-75.
PubMed Text format Related articles Abstract available

WOLTER DJ , Kurpiel PM, Woodford N, Palepou MF, et al
Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4.
Antimicrob Agents Chemother. 2009;53:557-62.
PubMed Text format Related articles Abstract available

MELLBYE BL , Puckett SE, Tilley LD, Iversen PL, et al
Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo.
Antimicrob Agents Chemother. 2009;53:525-30.
PubMed Text format Related articles Abstract available

LIEBERMAN LA , Higgins DE
A small-molecule screen identifies the antipsychotic drug pimozide as an inhibitor of Listeria monocytogenes infection.
Antimicrob Agents Chemother. 2009;53:756-64.
PubMed Text format Related articles Abstract available

DAI T , Tegos GP, Burkatovskaya M, Castano AP, et al
Chitosan acetate bandage as a topical antimicrobial dressing for infected burns.
Antimicrob Agents Chemother. 2009;53:393-400.
PubMed Text format Related articles Abstract available

DOUBLET B , Chu C, Chiu CH, Fan YC, et al
Truncated tni module adjacent to the complex integron of salmonella genomic island 1 in Salmonella enterica serovar Virchow.
Antimicrob Agents Chemother. 2009;53:824-7.
PubMed Text format Related articles Abstract available

PETERSEN PJ , Jones CH, Venkatesan AM, Mansour TS, et al
Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489.
Antimicrob Agents Chemother. 2009;53:370-84.
PubMed Text format Related articles Abstract available

IBRAHIM AS , Gebremariam T, Schwartz JA, Edwards JE Jr, et al
Posaconazole mono- or combination therapy for treatment of murine zygomycosis.
Antimicrob Agents Chemother. 2009;53:772-5.
PubMed Text format Related articles Abstract available

January 2009

SUN L , Sun S, Cheng A, Wu X, et al
In Vitro Activities of Retigeric acid B Alone and in Combination with Azole Antifungal Agents against Candida albicans.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

PERKHOFER S , Lechner V, Lass-Florl C
The In Vitro Activity of Isavuconazole against Aspergillus Species and Zygomycetes According to EUCAST Methodology.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

O'NEILL AJ , Lindsay JA, Gould K, Hinds J, et al
Transcriptional signature following inhibition of early-stage cell-wall biosynthesis in Staphylococcus aureus.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

OSTROSKY-ZEICHNER L , Paetznick VL, Rodriguez J, Chen E, et al
Activity of anidulafungin in a murine model of Candida krusei infection: Evaluation of mortality and disease burden by quantitative tissue cultures and serum (1,3)-{beta}-D-glucan levels.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

ZHANEL GG , Karlowsky JA
In Vitro Activity of Iclaprim Against Respiratory and Bacteremic Isolates of Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2009.
PubMed Text format Related articles Abstract available

GARCIA-EFFRON G , Park S, Perlin DS
Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints.
Antimicrob Agents Chemother. 2009;53:112-22.
PubMed Text format Related articles Abstract available

LOUIE T , Miller M, Donskey C, Mullane K, et al
Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection.
Antimicrob Agents Chemother. 2009;53:223-8.
PubMed Text format Related articles Abstract available

LOUIE TJ , Emery J, Krulicki W, Byrne B, et al
OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection.
Antimicrob Agents Chemother. 2009;53:261-3.
PubMed Text format Related articles Abstract available

CHACON-MORENO BE , Welsh O, Cavazos-Rocha N, de la Luz Salazar-Cavazos M, et al
Efficacy of ciprofloxacin and moxifloxacin against Nocardia brasiliensis in vitro and in an experimental model of actinomycetoma in BALB/c mice.
Antimicrob Agents Chemother. 2009;53:295-7.
PubMed Text format Related articles Abstract available

December 2008

WARBURG G , Korem M, Robicsek A, Engelstein D, et al
Changes in aac(6')-Ib-cr prevalence and fluoroquinolone resistance in nosocomial isolates of E. coli.: 1991-2005.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

OLSON RP , Harrell LJ, Kaye KS
Antibiotic Resistance to Escherichia coli in Urinary Isolates from College Women with Urinary Tract Infections.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

KIM HB , Park CH, Kim CJ, Kim EC, et al
Prevalence of Plasmid-Mediated Quinolone Resistance Determinants over a Nine-Year Period.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

YAGCI D , Yoruk F, Azap A, Memikoglu O, et al
THE PREVALENCE AND RISK FACTORS FOR THE SELECTION OF QUINOLONE RESISTANT ESCHERICHIA COLI IN FECAL FLORA OF PATIENTS RECEIVING QUINOLONE THERAPY.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

CAIRNS BJ , Payne RJ
Bacteriophage therapy and the mutant selection window.
Antimicrob Agents Chemother. 2008;52:4344-50.
PubMed Text format Related articles Abstract available

SNYDMAN DR , Jacobus NV, McDermott LA
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
Antimicrob Agents Chemother. 2008;52:4492-6.
PubMed Text format Related articles Abstract available

PILLAR CM , Torres MK, Brown NP, Shah D, et al
In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States.
Antimicrob Agents Chemother. 2008;52:4388-99.
PubMed Text format Related articles Abstract available

CIRIONI O , Ghiselli R, Silvestri C, Kamysz W, et al
Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis.
Antimicrob Agents Chemother. 2008;52:4351-5.
PubMed Text format Related articles Abstract available

November 2008

ZHENG B , Tomita H, Inoue T, Ike Y, et al
The Isolation of VanB-Type E. faecalis Strains From Nosocomial Infections: The First Report of Isolation and Identification of the Pheromone-Responsive Plasmids pMG2200 (106.5 kbp), Encoding VanB-Type Vancomycin Resistance and Bac41-Type Bacteriocin, and
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

ENRIQUEZ R , Abad R, Salcedo C, Vazquez JA, et al
Nalidixic Acid disk for laboratory detection of ciprofloxacin resistance in Neisseria meningitidis.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

WADE KC , Wu D, Kaufman DA, Ward RM, et al
Population pharmacokinetics of fluconazole in young infants.
Antimicrob Agents Chemother. 2008;52:4043-9.
PubMed Text format Related articles Abstract available

ROSSOLINI GM , Luzzaro F, Migliavacca R, Mugnaioli C, et al
First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
Antimicrob Agents Chemother. 2008;52:4023-9.
PubMed Text format Related articles Abstract available

BERTAZZONI MINELLI E , Benini A, Franco L, Bassi C, et al
Piperacillin-tazobactam penetration into human pancreatic juice.
Antimicrob Agents Chemother. 2008;52:4149-52.
PubMed Text format Related articles Abstract available

CALATAYUD L , Arnan M, Linares J, Dominguez MA, et al
Prospective study of fecal colonization by extended-spectrum-beta-lactamase-producing Escherichia coli in neutropenic patients with cancer.
Antimicrob Agents Chemother. 2008;52:4187-90.
PubMed Text format Related articles Abstract available

GARCIA-EFFRON G , Kontoyiannis DP, Lewis RE, Perlin DS, et al
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Antimicrob Agents Chemother. 2008;52:4181-3.
PubMed Text format Related articles Abstract available

SCHMIDTKE AJ , Hanson ND
Role of ampD homologs in overproduction of AmpC in clinical isolates of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2008;52:3922-7.
PubMed Text format Related articles Abstract available

KIM A , Suecof LA, Sutherland CA, Gao L, et al
In vivo microdialysis study of the penetration of daptomycin into soft tissues in diabetic versus healthy volunteers.
Antimicrob Agents Chemother. 2008;52:3941-6.
PubMed Text format Related articles Abstract available

SEKIGUCHI J , Morita K, Kitao T, Watanabe N, et al
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Antimicrob Agents Chemother. 2008;52:4194-7.
PubMed Text format Related articles Abstract available

DOOLEY K , Flexner C, Hackman J, Peloquin CA, et al
Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations.
Antimicrob Agents Chemother. 2008;52:4037-42.
PubMed Text format Related articles Abstract available

ADAMS-HADUCH JM , Paterson DL, Sidjabat HE, Pasculle AW, et al
Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania.
Antimicrob Agents Chemother. 2008;52:3837-43.
PubMed Text format Related articles Abstract available

TRACZEWSKI MM , Brown SD
Proposed MIC and disk diffusion microbiological cutoffs and spectrum of activity of retapamulin, a novel topical antimicrobial agent.
Antimicrob Agents Chemother. 2008;52:3863-7.
PubMed Text format Related articles Abstract available

ZONG Z , Partridge SR, Thomas L, Iredell JR, et al
Dominance of blaCTX-M within an Australian extended-spectrum beta-lactamase gene pool.
Antimicrob Agents Chemother. 2008;52:4198-202.
PubMed Text format Related articles Abstract available

KARLOWSKY JA , Laing NM, Zhanel GG
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.
Antimicrob Agents Chemother. 2008;52:4163-5.
PubMed Text format Related articles Abstract available

FERNANDEZ-ROBLAS R , Martin-de-Hijas NZ, Fernandez-Martinez AI, Garcia-Almeida D, et al
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
Antimicrob Agents Chemother. 2008;52:4184-6.
PubMed Text format Related articles Abstract available

DRUSANO GL , Okusanya OO, Okusanya A, Van Scoy B, et al
Is 60 days of ciprofloxacin administration necessary for postexposure prophylaxis for Bacillus anthracis?
Antimicrob Agents Chemother. 2008;52:3973-9.
PubMed Text format Related articles Abstract available

LI CR , Yang XY, Lou RH, Zhang WX, et al
In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
Antimicrob Agents Chemother. 2008;52:3875-82.
PubMed Text format Related articles Abstract available

PAN JC , Ye R, Wang HQ, Xiang HQ, et al
Vibrio cholerae O139 multiple-drug resistance mediated by Yersinia pestis pIP1202-like conjugative plasmids.
Antimicrob Agents Chemother. 2008;52:3829-36.
PubMed Text format Related articles Abstract available

SUGIMURA M , Maseda H, Hanaki H, Nakae T, et al
Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2008;52:4141-4.
PubMed Text format Related articles Abstract available

NAAS T , Namdari F, Bogaerts P, Huang TD, et al
Genetic structure associated with blaOXA-18, encoding a clavulanic acid-inhibited extended-spectrum oxacillinase.
Antimicrob Agents Chemother. 2008;52:3898-904.
PubMed Text format Related articles Abstract available

October 2008

MA J , Zeng Z, Chen Z, Xu X, et al
High Prevalence of Plasmid-Mediated Quinolone Resistance Determinants qnr, aac(6')-Ib-cr and qepA among Ceftiofur-Resistant Enterobacteriaceae Isolates from Companion and Food-Producing Animals.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

RODRIGUEZ MM , Serena C, Marine M, Pastor FJ, et al
Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae.
Antimicrob Agents Chemother. 2008;52:3786-8.
PubMed Text format Related articles Abstract available

LASS-FLORL C , Mayr A, Perkhofer S, Hinterberger G, et al
Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
Antimicrob Agents Chemother. 2008;52:3637-41.
PubMed Text format Related articles Abstract available

DOUBLET B , Praud K, Bertrand S, Collard JM, et al
Novel insertion sequence- and transposon-mediated genetic rearrangements in genomic island SGI1 of Salmonella enterica serovar Kentucky.
Antimicrob Agents Chemother. 2008;52:3745-54.
PubMed Text format Related articles Abstract available

CRAIG WA , Andes DR
In vivo pharmacodynamics of ceftobiprole against multiple bacterial pathogens in murine thigh and lung infection models.
Antimicrob Agents Chemother. 2008;52:3492-6.
PubMed Text format Related articles Abstract available

HANSON ND , Moland ES, Hong SG, Propst K, et al
Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community.
Antimicrob Agents Chemother. 2008;52:3814-6.
PubMed Text format Related articles Abstract available

WAITES KB , Crabb DM, Duffy LB
Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.
Antimicrob Agents Chemother. 2008;52:3776-8.
PubMed Text format Related articles Abstract available

DUBOIS V , Poirel L, Demarthe F, Arpin C, et al
Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.
Antimicrob Agents Chemother. 2008;52:3792-4.
PubMed Text format Related articles Abstract available

LO JY , Ho KM, Leung AO, Tiu FS, et al
Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection.
Antimicrob Agents Chemother. 2008;52:3564-7.
PubMed Text format Related articles Abstract available

ARENDRUP MC , Perkhofer S, Howard SJ, Garcia-Effron G, et al
Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.
Antimicrob Agents Chemother. 2008;52:3504-11.
PubMed Text format Related articles Abstract available

JUAN C , Beceiro A, Gutierrez O, Alberti S, et al
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
Antimicrob Agents Chemother. 2008;52:3589-96.
PubMed Text format Related articles Abstract available

CAVACO LM , Abatih E, Aarestrup FM, Guardabassi L, et al
Selection and persistence of CTX-M-producing Escherichia coli in the intestinal flora of pigs treated with amoxicillin, ceftiofur, or cefquinome.
Antimicrob Agents Chemother. 2008;52:3612-6.
PubMed Text format Related articles Abstract available

SKINDERSOE ME , Alhede M, Phipps R, Yang L, et al
Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2008;52:3648-63.
PubMed Text format Related articles Abstract available

PETRELLA S , Ziental-Gelus N, Mayer C, Renard M, et al
Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.
Antimicrob Agents Chemother. 2008;52:3725-36.
PubMed Text format Related articles Abstract available

ANDES DR , Diekema DJ, Pfaller MA, Marchillo K, et al
In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis model.
Antimicrob Agents Chemother. 2008;52:3497-503.
PubMed Text format Related articles Abstract available

September 2008

YANG H , Chen H, Yang Q, Chen M, et al
The High Prevalence of Plasmid-mediated Quinolone Resistance Genes (qnr) and aac(6')-Ib-cr in Clinical Isolates of Enterobacteriaceae from Nine Teaching Hospitals in China.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

MARQUEZ C , Labbate M, Ingold AJ, Chowdhury PR, et al
Recovery of a functional class 2 integron from an Escherichia coli strain mediating a urinary tract infection.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

CALDWELL DB , Wang Y, Lin J
Development, Stability, and Molecular Mechanisms of Macrolide Resistance in Campylobacter jejuni.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

BOGAERTS P , Cuzon G, Naas T, Bauraing C, et al
Carbapenem-Resistant Acinetobacter baumannii Expressing the blaOXA-23 Gene Associated to ISAba4 in Belgium.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

QIN X , Zerr DM, Weissman SJ, Englund JA, et al
Prevalence and Mechanisms of Broad-spectrum {beta}-lactam Resistance in Enterobacteriaceae: a Children's Hospital Experience.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

August 2008

ZARRILLI R , Vitale D, Di Popolo A, Bagattini M, et al
A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

TAMANG MD , Seol SY, Oh JY, Kang HY, et al
Plasmid-Mediated Quinolone Resistance Determinants qnrA, qnrB, and qnrS among Clinical Isolates of Enterobacteriaceae in a Korean Hospital.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

TANIMOTO K , Tomita H, Fujimoto S, Okuzumi K, et al
Fluoroquinolone enhanced the mutation frequency of meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high potency drug doripenem inhibited mutant formation.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

O'CONNOR JR , Galang MA, Sambol SP, Hecht DW, et al
Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile.
Antimicrob Agents Chemother. 2008;52:2813-7.
PubMed Text format Related articles Abstract available

PRANTING M , Negrea A, Rhen M, Andersson DI, et al
Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2.
Antimicrob Agents Chemother. 2008;52:2734-41.
PubMed Text format Related articles Abstract available

MILLER AA , Bundy GL, Mott JE, Skepner JE, et al
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
Antimicrob Agents Chemother. 2008;52:2806-12.
PubMed Text format Related articles Abstract available

PATEL N , McNutt LA, Lodise TP
Relationship between various definitions of prior antibiotic exposure and piperacillin-tazobactam resistance among patients with respiratory tract infections caused by Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2008;52:2933-6.
PubMed Text format Related articles Abstract available

SANCHEZ-CESPEDES J , Blasco MD, Marti S, Alba V, et al
Plasmid-mediated QnrS2 determinant from a clinical Aeromonas veronii isolate.
Antimicrob Agents Chemother. 2008;52:2990-1.
PubMed Text format Related articles

MARTI S , Sanchez-Cespedes J, Blasco MD, Ruiz M, et al
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
Antimicrob Agents Chemother. 2008;52:2955-8.
PubMed Text format Related articles Abstract available

CHUNG M , Antignac A, Kim C, Tomasz A, et al
Comparative study of the susceptibilities of major epidemic clones of methicillin-resistant Staphylococcus aureus to oxacillin and to the new broad-spectrum cephalosporin ceftobiprole.
Antimicrob Agents Chemother. 2008;52:2709-17.
PubMed Text format Related articles Abstract available

KIRATISIN P , Apisarnthanarak A, Laesripa C, Saifon P, et al
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
Antimicrob Agents Chemother. 2008;52:2818-24.
PubMed Text format Related articles Abstract available

LIM TP , Ledesma KR, Chang KT, Hou JG, et al
Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii.
Antimicrob Agents Chemother. 2008;52:2898-904.
PubMed Text format Related articles Abstract available

ESPEDIDO BA , Partridge SR, Iredell JR
bla(IMP-4) in different genetic contexts in Enterobacteriaceae isolates from Australia.
Antimicrob Agents Chemother. 2008;52:2984-7.
PubMed Text format Related articles Abstract available

MATSUI H , Aikawa C, Sekiya Y, Takahashi S, et al
Evaluation of antibiotic therapy for eradication of "Candidatus Helicobacter heilmannii".
Antimicrob Agents Chemother. 2008;52:2988-9.
PubMed Text format Related articles Abstract available

GARZA-RAMOS U , Morfin-Otero R, Sader HS, Jones RN, et al
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
Antimicrob Agents Chemother. 2008;52:2943-6.
PubMed Text format Related articles Abstract available

RESSNER RA , Griffith ME, Beckius ML, Pimentel G, et al
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Antimicrob Agents Chemother. 2008;52:2750-4.
PubMed Text format Related articles Abstract available

July 2008

WIEGAND I , Marr AK, Breidenstein EB, Schurek KN, et al
Mutator genes giving rise to decreased antibiotic susceptibility in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

SHIMIZU K , Kikuchi K, Sasaki T, Takahashi N, et al
Smqnr, a new chromosome-encoded quinolone resistance gene in Stenotrophomonas maltophilia.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

WOLFF BJ , Thacker WL, Schwartz SB, Winchell JM, et al
Detection of Macrolide Resistance in Mycoplasma pneumoniae by Real-Time PCR and High Resolution Melt Analysis.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

CATTOIR V , Poirel L, Nordmann P
Plasmid-Mediated Quinolone Resistance QepA2 from Escherichia coli in France.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

MOYA B , Juan C, Alberti S, Perez JL, et al
Benefit of having multiple ampD genes for acquiring {beta}-lactam resistance without losing fitness and virulence of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2008.
PubMed Text format Related articles Abstract available

June 2008

CARRER A , Poirel L, Eraksoy H, Cagatay AA, et al
Spread of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae in Istanbul, Turkey.
Antimicrob Agents Chemother. 2008;.
PubMed Text format Related articles Abstract available

May 2008

GARCIA-COBOS S , Campos J, Cercenado E, Roman F, et al
Antibiotic Resistance in Haemophilus influenzae is decreasing, except for {beta}-lactamase-negative amoxicillin-resistant isolates, in parallel to community antibiotic consumption (Spain, 1997-2007).
Antimicrob Agents Chemother. 2008;.
PubMed Text format Related articles Abstract available

VASILAKI O , Ntokou E, Ikonomidis A, Sofianou D, et al
Emergence of the plasmid-mediated quinolone resistance gene qnrS1 in Escherichia coli genotypes in Greece.
Antimicrob Agents Chemother. 2008;.
PubMed Text format Related articles Abstract available

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.
Design: